当前位置:首页 - 行情中心 - 华纳药厂(688799) - 财务分析

华纳药厂

(688799)

  

流通市值:74.27亿  总市值:74.27亿
流通股本:1.31亿   总股本:1.31亿

华纳药厂(688799)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.27亿元,每股收益0.20元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益207583.08万元,未分配利润101733.49万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产324017.52万元,负债116434.44万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入324,546,325.121,504,231,254.461,085,824,496.38713,712,049.73
营业总成本292,515,876.271,359,745,544.14966,629,718.63644,841,020.86
其他经营收益
营业利润33,189,779.01240,484,942.22216,523,407.3475,892,847.81
利润总额33,188,649.26240,895,081215,830,132.7475,222,005.08
净利润26,876,979.68228,098,328.6196,942,553.2962,119,334.13
每股收益
其他综合收益----
综合收益总额26,876,979.68228,098,328.6196,942,553.2962,119,334.13
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计1,106,687,552.081,176,225,379.931,426,300,751.461,353,122,606.13
非流动资产:
非流动资产合计2,133,487,631.941,877,418,088.931,354,543,424.131,172,483,983.38
资产总计3,240,175,184.023,053,643,468.862,780,844,175.592,525,606,589.51
流动负债:
流动负债合计391,168,967.12410,702,784.87334,762,565.42336,038,055.69
非流动负债:
非流动负债合计773,175,454.01600,255,786.38453,961,380.22331,418,074.38
负债合计1,164,344,421.131,010,958,571.25788,723,945.64667,456,130.07
所有者权益(或股东权益):
归属于母公司股东权益合计2,075,830,762.892,042,684,897.611,992,120,229.951,841,293,984.81
股东权益合计2,075,830,762.892,042,684,897.611,992,120,229.951,858,150,459.44
负债和股东权益合计3,240,175,184.023,053,643,468.862,780,844,175.592,525,606,589.51
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计319,304,553.271,397,762,072.381,085,609,543.33682,358,575.45
经营活动现金流出小计246,251,535.651,097,561,561.72879,301,082.47600,281,573.61
经营活动产生的现金流量净额73,053,017.62300,200,510.66206,308,460.8682,077,001.84
投资活动产生的现金流量:
投资活动现金流入小计100,183,567.85651,180,864.88486,231,065.33405,782,019.76
投资活动现金流出小计358,689,970.431,260,355,569.51867,395,039.65553,844,284.44
投资活动产生的现金流量净额-258,506,402.58-609,174,704.63-381,163,974.32-148,062,264.68
筹资活动产生的现金流量:
筹资活动现金流入小计174,398,227398,970,229.4253,226,643.74131,719,257.52
筹资活动现金流出小计3,817,650.1262,964,210.3459,762,262.2557,931,865.76
筹资活动产生的现金流量净额170,580,576.88336,006,019.06193,464,381.4973,787,391.76
汇率变动对现金及现金等价物的影响-645,151.4-993,338.01-407,517.58-145,063.05
现金及现金等价物净增加额-15,517,959.4826,038,487.0818,201,350.457,657,065.87
期末现金及现金等价物余额185,960,468.18201,478,427.66193,641,291.03183,097,006.45
补充资料:
现金及现金等价物的净增加额-26,038,487.08-7,657,065.87
最新报告期:2026-04-30
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
方正证券许睿,周超泽,李霁阳1.421.601.872026-04-30
方正证券许睿,周超泽,李霁阳1.802.00--2026-02-09
TOP↑